Skip to main content

Table 1 Basal endocrine evaluation

From: Pituitary metastasis of hepatocellular carcinoma presenting with panhypopituitarism: a case report

Hormone

Level measured

Normal levels

GH

0.360 ng/mL

0.010–3.607 ng/mL

PRL

6.83 ng/mL

<12.3 ng/mL

TSH

1.288 μIU/mL

0.350–4.940 μIU/mL

FT3

1.78 pg/mL

1.71–3.71 pg/mL

FT4

<0.40 ng/dL

0.70–1.48 ng/dL

ACTH

1.4 pg/mL

7.2–63.3 pg/mL

Cortisol

3.1 μg/dL

4.0–19.3 μg/dL

Aldosterone

10 pg/mL

36–240 pg/mL

Plasma renin activity

0.5 ng/mL

0.2–3.9 ng/mL

ADH

0.27 pg/mL

0.3–4.2 pg/mL

LH

<0.10 mIU/mL

7.5–56.2 mIU/mL

FSH

0.27 mIU/mL

9.2–124.7 mIU/mL

  1. Bold text indicates abnormal data
  2. GH: growth hormone, PRL: prolactin, TSH: thyroid-stimulating hormone, FT3: free triiodothyronine, FT4: free thyroxine, ACTH: adrenocorticotropic hormone, ADH: antidiuretic hormone, LH: luteinizing hormone, FSH: follicle-stimulating hormone